MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.07 (2.98%)	-0.02 (-0.82%)	0.0 (0.0%)	-0.1 (-3.97%)	0.07 (2.98%)	-0.01 (-0.75%)	0.9 (67.67%)	1.09 (81.95%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -26.8889
Diluted P/E:: -26.8889
RSI(14) 1m:: 26.32
VWAP:: 2.42
RVol:: 11.5393

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.32 +0.04 (+1.75%)	Oct 16 04:45
1m	Price increase 1m	2.3 +0.04 (+1.77%)	Oct 16 04:42
1m	Price decrease 1m	2.26 -0.07 (-3.0%)	Oct 16 04:41
10m	Price decrease 10m	2.26 -0.11 (-4.64%)	Oct 16 04:41
1m	Price decrease 1m	2.33 -0.04 (-1.69%)	Oct 16 04:40